Wei-Xian Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei-Xian Chen has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
Bei Zhu
10 shared publicationsLin Cheng
Jiangsu Breast Disease Center, the First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, Nanjing 210029, China
6 shared publicationsQuan-Feng Shao
6 shared publicationsZi-Ying Wang
6 shared publicationsQi Qian
Department of Breast Surgery, The Second Affiliated Changzhou People's Hospital of Nanjing Medical University, Changzhou, Jiangsu 213000, P.R. China
5 shared publicationsWei Liang
5 shared publications
Latest Publications
- Open Access
- 1 August 2026
- Published by AME Publishing Company in Gland Surgery
- Vol. 15 (8) , 221
Utility of intercostal artery perforator flap in granulomatous lobular mastitis: a single-center retrospective study
Background: Determining a procedure to fill operation defects, maintain breast shape, and conceal surgical incisions remains a challenge for breast surgeons in treating granulomatous lobular mastitis (GLM). The intercostal artery perforator (ICAP) flap is a volume replacement technique in breast-conserving surgery. This study aimed to describe the feasibility, safety, and patient-reported outcomes of extended mass resection and breast defect reconstruction with an ICAP flap in selected GLM patients. Methods: We retrospectively analyzed the data of 108 GLM patients treated surgically between January 2022 and May 2024 at our center. Patients were divided into three groups according to the actual surgical strategy received in routine clinical practice. The no reconstruction group was considered the main clinical comparator for the flap reconstruction group, whereas the no resection group was retained as an exploratory real-world reference group. Results: A total of 43 patients underwent extended mass resection and defect reconstruction with an ICAP flap (flap reconstruction group), 37 patients underwent extended mass resection without breast defect reconstruction (no reconstruction group), and 28 patients continued with abscess drainage or fistula removal without mass resection (no resection group). The flap reconstruction group showed longer surgery times and drainage removal times, as well as more blood loss and drainage volumes, than the other groups (P0.05). Compared with the no reconstruction group, the flap reconstruction group showed better patient-reported cosmetic change and higher satisfaction scores (PConclusions: Extended mass resection and breast defect reconstruction with an ICAP flap appears to be a feasible and safe option for selected GLM patients requiring resection, with potential advantages in maintaining breast appearance and improving patient-reported satisfaction. The observed recurrence difference should be interpreted cautiously because of the retrospective design, limited sample size, and short follow-up.
- 1 August 2026
- Published by AME Publishing Company in Gland Surgery
- Vol. 15 (8) , 221
Open AccessUtility of intercostal artery perforator flap in granulomatous lobular mastitis: a single-center retrospective study
Background: Determining a procedure to fill operation defects, maintain breast shape, and conceal surgical incisions remains a challenge for breast surgeons in treating granulomatous lobular mastitis (GLM). The intercostal artery perforator (ICAP) flap is a volume replacement technique in breast-conserving surgery. This study aimed to describe the feasibility, safety, and patient-reported outcomes of extended mass resection and breast defect reconstruction with an ICAP flap in selected GLM patients. Methods: We retrospectively analyzed the data of 108 GLM patients treated surgically between January 2022 and May 2024 at our center. Patients were divided into three groups according to the actual surgical strategy received in routine clinical practice. The no reconstruction group was considered the main clinical comparator for the flap reconstruction group, whereas the no resection group was retained as an exploratory real-world reference group. Results: A total of 43 patients underwent extended mass resection and defect reconstruction with an ICAP flap (flap reconstruction group), 37 patients underwent extended mass resection without breast defect reconstruction (no reconstruction group), and 28 patients continued with abscess drainage or fistula removal without mass resection (no resection group). The flap reconstruction group showed longer surgery times and drainage removal times, as well as more blood loss and drainage volumes, than the other groups (P0.05). Compared with the no reconstruction group, the flap reconstruction group showed better patient-reported cosmetic change and higher satisfaction scores (PConclusions: Extended mass resection and breast defect reconstruction with an ICAP flap appears to be a feasible and safe option for selected GLM patients requiring resection, with potential advantages in maintaining breast appearance and improving patient-reported satisfaction. The observed recurrence difference should be interpreted cautiously because of the retrospective design, limited sample size, and short follow-up.
- Open Access
- 1 July 2026
- Published by AME Publishing Company in Gland Surgery
- Vol. 15 (7) , 194
Standard imaging-guided chest wall perforator flap reconstruction without intraoperative handheld Doppler for granulomatous lobular mastitis: a simplified approach for resource-limited settings
Background: Surgical management of granulomatous lobular mastitis (GLM) requires balancing complete lesion excision with the preservation of breast aesthetics. While the chest wall perforator flap (CWPF) is a valuable volume replacement technique, its clinical adoption may be limited by the need for intraoperative handheld Doppler localization and specialized training. This study aimed to evaluate the efficacy of a simplified CWPF reconstruction approach guided by multimodal preoperative imaging and performed without intraoperative handheld Doppler. Methods: A retrospective analysis was performed on 80 patients diagnosed with GLM between January 2022 and May 2024. Patients were assigned to two groups: Group A (n=43) underwent extended mass resection followed by modified CWPF reconstruction without intraoperative handheld Doppler, while Group B (n=37) received conventional surgical therapy (simple lumpectomy, extended mass resection, or segmental mastectomy without reconstruction). Group A was managed via a multimodal imaging protocol: magnetic resonance imaging (MRI) for source vessel identification, computed tomography (CT) for skeletal landmark referencing, and ultrasound for surface marking, thereby eliminating the need for intraoperative handheld Doppler localization. Results: All CWPF flaps were harvested under preoperative imaging guidance without the use of a handheld Doppler device. Postoperative complication rate was comparable between groups, mainly involving delayed wound healing, positive bacterial culture, subcutaneous fat liquefaction, incision infection, nipple-areola ischemic necrosis, ecchymosis, or hematoma (all P>0.05). Notably, Group A achieved significantly superior cosmetic outcomes compared with Group B (PConclusions: Precise preoperative planning using multimodal imaging (MRI, CT, ultrasound) enables safe and effective CWPF reconstruction without intraoperative handheld Doppler in GLM surgery. This streamlined approach maintains surgical precision and favorable aesthetic outcomes while potentially reducing dependence on additional intraoperative localization devices, and may represent a practical strategy for breast reconstruction in resource-limited settings.
- 1 July 2026
- Published by AME Publishing Company in Gland Surgery
- Vol. 15 (7) , 194
Open AccessStandard imaging-guided chest wall perforator flap reconstruction without intraoperative handheld Doppler for granulomatous lobular mastitis: a simplified approach for resource-limited settings
Background: Surgical management of granulomatous lobular mastitis (GLM) requires balancing complete lesion excision with the preservation of breast aesthetics. While the chest wall perforator flap (CWPF) is a valuable volume replacement technique, its clinical adoption may be limited by the need for intraoperative handheld Doppler localization and specialized training. This study aimed to evaluate the efficacy of a simplified CWPF reconstruction approach guided by multimodal preoperative imaging and performed without intraoperative handheld Doppler. Methods: A retrospective analysis was performed on 80 patients diagnosed with GLM between January 2022 and May 2024. Patients were assigned to two groups: Group A (n=43) underwent extended mass resection followed by modified CWPF reconstruction without intraoperative handheld Doppler, while Group B (n=37) received conventional surgical therapy (simple lumpectomy, extended mass resection, or segmental mastectomy without reconstruction). Group A was managed via a multimodal imaging protocol: magnetic resonance imaging (MRI) for source vessel identification, computed tomography (CT) for skeletal landmark referencing, and ultrasound for surface marking, thereby eliminating the need for intraoperative handheld Doppler localization. Results: All CWPF flaps were harvested under preoperative imaging guidance without the use of a handheld Doppler device. Postoperative complication rate was comparable between groups, mainly involving delayed wound healing, positive bacterial culture, subcutaneous fat liquefaction, incision infection, nipple-areola ischemic necrosis, ecchymosis, or hematoma (all P>0.05). Notably, Group A achieved significantly superior cosmetic outcomes compared with Group B (PConclusions: Precise preoperative planning using multimodal imaging (MRI, CT, ultrasound) enables safe and effective CWPF reconstruction without intraoperative handheld Doppler in GLM surgery. This streamlined approach maintains surgical precision and favorable aesthetic outcomes while potentially reducing dependence on additional intraoperative localization devices, and may represent a practical strategy for breast reconstruction in resource-limited settings.
- Open Access
- 17 June 2026
- Published by Springer Nature in Biology Direct
- Vol. 21 (1)
Hypoxia and lactate metabolism-related gene COL5A3 promotes triple negative breast cancer progression via DDR1/FAK/PI3K/AKT pathway
Triple-negative breast cancer (TNBC) is a highly aggressive subtype characterized by a lack of hormone receptors and specific molecular targets, leading to limited treatment options, high recurrence rates, and poor clinical prognosis. The Warburg effect in cancer cells generates a tumor microenvironment characterized by hypoxia, low glucose, and high lactate levels, which severely promotes chemoresistance, immune escape, and distant metastasis. Nevertheless, the prognostic significance of hypoxia and lactate metabolism-related genes in TNBC remains largely unclear, and more accurate prediction models are urgently needed. Clinical information and gene expression profiles of patients with TNBC were obtained from online databases. LASSO and multivariate Cox regression analyses were used to establish the hypoxia and lactate metabolism-related prediction model, and the prognostic value was further validated using Kaplan-Meier plotter, receiver operating characteristic curves, and nomogram. Gene set enrichment analysis was performed to evaluate the pathways and molecular functions. Tumor mutation, microsatellite instability, RNA expression-based stemness scores, immune infiltration, and drug susceptibility analyses were performed to identify potential therapeutic targets. Single-cell transcriptome data were processed and quality-controlled using Seurat. Monocle2, CellChat, and ssGSEA analyses were used to investigate the relationship between COL5A3, malignant phenotype, and tumor microenvironment. A series of in vitro experiments was performed to evaluate the biological functions of hub gene COL5A3. Five genes, COL5A3, LRRC8D, IGFL1, SEPTIN3, and PEG10, were identified to establish the hypoxia and lactate metabolism-related risk score. TNBC patients divided into high-risk or low-risk groups according to the risk score exhibited substantial differences in survival outcome, tumor mutation, immune infiltration, and drug sensitivity. The constructed model showed strong predictive performance, with receiver operating characteristic curves showing area under the curve values of 0.82, 0.86, and 0.90 at 365, 1085, and 1825 days, respectively. Single-cell analysis showed that high COL5A3 expression was associated with greater proliferative capacity, drug resistance, and stemness. COL5A3 is also involved in regulating the interaction between TNBC cells and other cells in the tumor microenvironment. In vitro studies have indicated that COL5A3 could promote tumor proliferation, migration, invasion, and drug resistance via the DDR1/FAK/PI3K/AKT pathway in TNBC cells. OF-1 was initially identified as a candidate compound with potential therapeutic relevance for TNBC. A novel hypoxia and lactate metabolism-related gene signature could be used for prognosis prediction in TNBC patients, and the hub gene COL5A3 promotes TNBC progression via the DDR1/FAK/PI3K/AKT pathway. Further research is needed to explore the biological roles of these genes in TNBC to refine the therapeutic approaches.
- 17 June 2026
- Published by Springer Nature in Biology Direct
- Vol. 21 (1)
Open AccessHypoxia and lactate metabolism-related gene COL5A3 promotes triple negative breast cancer progression via DDR1/FAK/PI3K/AKT pathway
Triple-negative breast cancer (TNBC) is a highly aggressive subtype characterized by a lack of hormone receptors and specific molecular targets, leading to limited treatment options, high recurrence rates, and poor clinical prognosis. The Warburg effect in cancer cells generates a tumor microenvironment characterized by hypoxia, low glucose, and high lactate levels, which severely promotes chemoresistance, immune escape, and distant metastasis. Nevertheless, the prognostic significance of hypoxia and lactate metabolism-related genes in TNBC remains largely unclear, and more accurate prediction models are urgently needed. Clinical information and gene expression profiles of patients with TNBC were obtained from online databases. LASSO and multivariate Cox regression analyses were used to establish the hypoxia and lactate metabolism-related prediction model, and the prognostic value was further validated using Kaplan-Meier plotter, receiver operating characteristic curves, and nomogram. Gene set enrichment analysis was performed to evaluate the pathways and molecular functions. Tumor mutation, microsatellite instability, RNA expression-based stemness scores, immune infiltration, and drug susceptibility analyses were performed to identify potential therapeutic targets. Single-cell transcriptome data were processed and quality-controlled using Seurat. Monocle2, CellChat, and ssGSEA analyses were used to investigate the relationship between COL5A3, malignant phenotype, and tumor microenvironment. A series of in vitro experiments was performed to evaluate the biological functions of hub gene COL5A3. Five genes, COL5A3, LRRC8D, IGFL1, SEPTIN3, and PEG10, were identified to establish the hypoxia and lactate metabolism-related risk score. TNBC patients divided into high-risk or low-risk groups according to the risk score exhibited substantial differences in survival outcome, tumor mutation, immune infiltration, and drug sensitivity. The constructed model showed strong predictive performance, with receiver operating characteristic curves showing area under the curve values of 0.82, 0.86, and 0.90 at 365, 1085, and 1825 days, respectively. Single-cell analysis showed that high COL5A3 expression was associated with greater proliferative capacity, drug resistance, and stemness. COL5A3 is also involved in regulating the interaction between TNBC cells and other cells in the tumor microenvironment. In vitro studies have indicated that COL5A3 could promote tumor proliferation, migration, invasion, and drug resistance via the DDR1/FAK/PI3K/AKT pathway in TNBC cells. OF-1 was initially identified as a candidate compound with potential therapeutic relevance for TNBC. A novel hypoxia and lactate metabolism-related gene signature could be used for prognosis prediction in TNBC patients, and the hub gene COL5A3 promotes TNBC progression via the DDR1/FAK/PI3K/AKT pathway. Further research is needed to explore the biological roles of these genes in TNBC to refine the therapeutic approaches.
- Open Access
- 4 April 2026
- Published by SAGE Publications in Breast Cancer: Basic and Clinical Research
- Vol. 20
Genes From Epithelial-Mesenchymal Transition Predict Overall Survival Effectively in Breast Cancer: A Novel Risk Model Based on Initial Step of Tumor Metastasis
Background: Accumulating evidence has demonstrated that epithelial-mesenchymal transition (EMT) plays a critical role in breast cancer (BRCA) initiation, invasion, metastasis, and prognosis. Objectives: To develop and validate a comprehensive EMT-related gene signature for robust prognosis prediction in BRCA. Design: Retrospective multi-cohort study. Methods: We obtained 1223 BRCA samples from The Cancer Genome Atlas (TCGA) and 1184 EMT-related genes from the dbEMT2.0 public database. Prognostic genes were selected via univariate Cox and LASSO regression analyses to construct a risk score model, which was subsequently validated in independent internal cohort (TCGA) and external cohorts (UCSC and GEO). Finally, a nomogram integrating the risk score with clinical parameters was established. Results: A 15-gene EMT signature was identified and used to stratify patients into high- and low-risk groups. The high-risk group exhibited significantly poorer overall survival in the TCGA cohort ( P < .05), a finding consistently validated across 4 independent datasets (all P < .05). The risk score served as an independent prognostic factor (hazard ratio = 2.386, P < .001). The integrative nomogram, incorporating the risk score, age, and N and M stages, demonstrated moderate accuracy for survival prediction (C-index = 0.711). Conclusions: We developed and validated a novel 15-gene EMT signature and a corresponding nomogram, which provide a potential tool for prognostic stratification in BRCA patients.
- 4 April 2026
- Published by SAGE Publications in Breast Cancer: Basic and Clinical Research
- Vol. 20
Open AccessGenes From Epithelial-Mesenchymal Transition Predict Overall Survival Effectively in Breast Cancer: A Novel Risk Model Based on Initial Step of Tumor Metastasis
Background: Accumulating evidence has demonstrated that epithelial-mesenchymal transition (EMT) plays a critical role in breast cancer (BRCA) initiation, invasion, metastasis, and prognosis. Objectives: To develop and validate a comprehensive EMT-related gene signature for robust prognosis prediction in BRCA. Design: Retrospective multi-cohort study. Methods: We obtained 1223 BRCA samples from The Cancer Genome Atlas (TCGA) and 1184 EMT-related genes from the dbEMT2.0 public database. Prognostic genes were selected via univariate Cox and LASSO regression analyses to construct a risk score model, which was subsequently validated in independent internal cohort (TCGA) and external cohorts (UCSC and GEO). Finally, a nomogram integrating the risk score with clinical parameters was established. Results: A 15-gene EMT signature was identified and used to stratify patients into high- and low-risk groups. The high-risk group exhibited significantly poorer overall survival in the TCGA cohort ( P < .05), a finding consistently validated across 4 independent datasets (all P < .05). The risk score served as an independent prognostic factor (hazard ratio = 2.386, P < .001). The integrative nomogram, incorporating the risk score, age, and N and M stages, demonstrated moderate accuracy for survival prediction (C-index = 0.711). Conclusions: We developed and validated a novel 15-gene EMT signature and a corresponding nomogram, which provide a potential tool for prognostic stratification in BRCA patients.
- Open Access
- 30 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
M2 macrophages predict response to neoadjuvant chemotherapy in triple negative breast cancer patients
Macrophages, the predominant immune-related stromal cells within tumor microenvironment, could be polarized into M1 and alternative M2 macrophages. M1 macrophages are pro-inflammatory and eliminate cancer cells, whereas M2 macrophages are immunosuppressive and facilitate tumor growth. Mounting evidence has shown that M2 macrophages are responsible for a poor prognosis in triple negative breast cancer (TNBC) patients. Since neoadjuvant chemotherapy is becoming the foundation treatment for TNBC, the relationship between M2 macrophages and response to neoadjuvant chemotherapy remains to be elucidated. Infiltration of M2 macrophages were checked by analyzing the CD163 levels on surgical resection specimens from 42 Chinese TNBC patients treated with neoadjuvant chemotherapy. Evaluation of M2 macrophages together with other immune markers including CD8-positive cytotoxic T cells and PD-L1 expression in TNBC and its association with pCR after neoadjuvant chemotherapy were performed. Pathological complete response (pCR) was significantly associated with younger age, higher tumor or stromal PD-L1 expression, higher levels of tumor or stromal CD8-positive cytotoxic T cells, but lower infiltration of CD163-positive M2 macrophages, with the level of CD163-positive M2 macrophages in stromal area as the strongest factor. Our study showed that high infiltration of CD163-positive M2 macrophages was negatively associated with the chemotherapeutic response to neoadjuvant chemotherapy in Chinese TNBC patients and could be used as a promising prognostic candidate for Chinese TNBC patients treated with neoadjuvant chemotherapy.
- 30 March 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessM2 macrophages predict response to neoadjuvant chemotherapy in triple negative breast cancer patients
Macrophages, the predominant immune-related stromal cells within tumor microenvironment, could be polarized into M1 and alternative M2 macrophages. M1 macrophages are pro-inflammatory and eliminate cancer cells, whereas M2 macrophages are immunosuppressive and facilitate tumor growth. Mounting evidence has shown that M2 macrophages are responsible for a poor prognosis in triple negative breast cancer (TNBC) patients. Since neoadjuvant chemotherapy is becoming the foundation treatment for TNBC, the relationship between M2 macrophages and response to neoadjuvant chemotherapy remains to be elucidated. Infiltration of M2 macrophages were checked by analyzing the CD163 levels on surgical resection specimens from 42 Chinese TNBC patients treated with neoadjuvant chemotherapy. Evaluation of M2 macrophages together with other immune markers including CD8-positive cytotoxic T cells and PD-L1 expression in TNBC and its association with pCR after neoadjuvant chemotherapy were performed. Pathological complete response (pCR) was significantly associated with younger age, higher tumor or stromal PD-L1 expression, higher levels of tumor or stromal CD8-positive cytotoxic T cells, but lower infiltration of CD163-positive M2 macrophages, with the level of CD163-positive M2 macrophages in stromal area as the strongest factor. Our study showed that high infiltration of CD163-positive M2 macrophages was negatively associated with the chemotherapeutic response to neoadjuvant chemotherapy in Chinese TNBC patients and could be used as a promising prognostic candidate for Chinese TNBC patients treated with neoadjuvant chemotherapy.
- Open Access
- 19 January 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 45, 102456
Recognition of immunogenomic signature and prognostic value of the subtype of epithelial-mesenchymal transition in breast cancer
- 19 January 2026
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 45, 102456
Open AccessRecognition of immunogenomic signature and prognostic value of the subtype of epithelial-mesenchymal transition in breast cancer
- Open Access
- 12 June 2025
- Published by Wiley in Cancer Science
- Vol. 116 (9) , 2547-2567
Engineered EVs‐Mediated miR‐222 Targeting PTEN/FN1 Axis Reverses Anthracycline Resistance in HER2‐Negative Breast Cancer
Anthracycline resistance represents a critical therapeutic challenge in breast cancer treatment, wherein alterations in the tumor immune microenvironment and enhanced cellular resistance mechanisms facilitate chemoresistance progression. Transcriptome analysis of 142 HER2‐negative breast cancer patients undergoing anthracycline‐based chemotherapy revealed four distinct tumor‐infiltrating cell subtypes, with subtype D exhibiting elevated M1 macrophage infiltration and superior prognostic outcomes. Differential expression analysis identified miR‐222 as the predominantly upregulated microRNA in adriamycin‐resistant cells, while Tandem Mass Tag mass spectrometry‐based quantitative analysis elucidated PTEN as its direct target and FN1 as a crucial downstream mediator. Engineered extracellular vesicles (EVs) carrying a miR‐222 inhibitor were developed to reverse adriamycin resistance via PTEN/FN1 signaling modulation. Molecular docking analysis found specific PTEN‐FN1 protein interactions characterized by stable hydrogen bonds at ARG142‐ASP23 and ARG15‐GLU95. In xenograft models, EVs‐mediated delivery of the miR‐222 inhibitor significantly attenuated MCF‐7/ADR tumor progression through miR‐222 suppression and PTEN restoration, with concordant molecular alterations observed in serum‐derived EVs. Our findings establish a novel mechanism of EVs‐mediated drug resistance through the microRNA‐222/PTEN/FN1 axis and present Engineered EVs as a promising therapeutic strategy for anthracycline resistance in breast cancer, while highlighting circulating EVs profiles as potential treatment monitoring biomarkers.
- 12 June 2025
- Published by Wiley in Cancer Science
- Vol. 116 (9) , 2547-2567
Open AccessEngineered EVs‐Mediated miR‐222 Targeting PTEN/FN1 Axis Reverses Anthracycline Resistance in HER2‐Negative Breast Cancer
Anthracycline resistance represents a critical therapeutic challenge in breast cancer treatment, wherein alterations in the tumor immune microenvironment and enhanced cellular resistance mechanisms facilitate chemoresistance progression. Transcriptome analysis of 142 HER2‐negative breast cancer patients undergoing anthracycline‐based chemotherapy revealed four distinct tumor‐infiltrating cell subtypes, with subtype D exhibiting elevated M1 macrophage infiltration and superior prognostic outcomes. Differential expression analysis identified miR‐222 as the predominantly upregulated microRNA in adriamycin‐resistant cells, while Tandem Mass Tag mass spectrometry‐based quantitative analysis elucidated PTEN as its direct target and FN1 as a crucial downstream mediator. Engineered extracellular vesicles (EVs) carrying a miR‐222 inhibitor were developed to reverse adriamycin resistance via PTEN/FN1 signaling modulation. Molecular docking analysis found specific PTEN‐FN1 protein interactions characterized by stable hydrogen bonds at ARG142‐ASP23 and ARG15‐GLU95. In xenograft models, EVs‐mediated delivery of the miR‐222 inhibitor significantly attenuated MCF‐7/ADR tumor progression through miR‐222 suppression and PTEN restoration, with concordant molecular alterations observed in serum‐derived EVs. Our findings establish a novel mechanism of EVs‐mediated drug resistance through the microRNA‐222/PTEN/FN1 axis and present Engineered EVs as a promising therapeutic strategy for anthracycline resistance in breast cancer, while highlighting circulating EVs profiles as potential treatment monitoring biomarkers.
- Open Access
Construction of a novel five programmed cell death-related gene signature as a promising prognostic model for triple negative breast cancer
Background: Triple negative breast cancer (TNBC) is a more aggressive subtype of breast cancer that usually progresses rapidly, develops drug resistance, metastasis, and relapses, and remains a challenge for clinicians to treat. Programmed cell death (PCD), a conserved mechanism of cell suicide controlled by various pathways, contributed to carcinogenesis and cancer progression. Nevertheless, the prognostic significance of PCD-related genes in TNBC remains largely unclear, and more accurate prognostic models are urgently needed. Methods: Gene expression profiles and clinical information of TNBC patients were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database. Least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analysis were used to establish the PCD-related gene signature. Kaplan-Meier plotter, receiver operating characteristic curves, and nomogram were applied to validate the prognostic value of the gene signature. Gene set enrichment analysis was carried out to investigate the pathways and molecular functions. Results: Five PCD-related genes including SEPTIN3, SCARB1, CHML, SYNM, and COL5A3 were identified to establish the PCD-related risk score for TNBC patients. Patients stratified into high-risk or low-risk group showed significantly different survival outcome, immune infiltration, and drug susceptibility. Kaplan-Meier and receiver operating characteristic curves showed a good performance for survival prediction in different cohorts. Gene set enrichment analysis revealed that the five-gene signature was associated with tumor metabolism, cancer cell proliferation, invasion and metastasis, and tumor microenvironment. Nomogram including the five-gene signature was established. Conclusion: A novel five PCD-related gene signature and nomogram could be used for prognostic prediction in TNBC. The present work might offer useful insights in digging sensitive and effective biomarkers for TNBC prognosis prediction and establishing accurate prognostic model in clinical management.
Open AccessConstruction of a novel five programmed cell death-related gene signature as a promising prognostic model for triple negative breast cancer
Background: Triple negative breast cancer (TNBC) is a more aggressive subtype of breast cancer that usually progresses rapidly, develops drug resistance, metastasis, and relapses, and remains a challenge for clinicians to treat. Programmed cell death (PCD), a conserved mechanism of cell suicide controlled by various pathways, contributed to carcinogenesis and cancer progression. Nevertheless, the prognostic significance of PCD-related genes in TNBC remains largely unclear, and more accurate prognostic models are urgently needed. Methods: Gene expression profiles and clinical information of TNBC patients were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database. Least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analysis were used to establish the PCD-related gene signature. Kaplan-Meier plotter, receiver operating characteristic curves, and nomogram were applied to validate the prognostic value of the gene signature. Gene set enrichment analysis was carried out to investigate the pathways and molecular functions. Results: Five PCD-related genes including SEPTIN3, SCARB1, CHML, SYNM, and COL5A3 were identified to establish the PCD-related risk score for TNBC patients. Patients stratified into high-risk or low-risk group showed significantly different survival outcome, immune infiltration, and drug susceptibility. Kaplan-Meier and receiver operating characteristic curves showed a good performance for survival prediction in different cohorts. Gene set enrichment analysis revealed that the five-gene signature was associated with tumor metabolism, cancer cell proliferation, invasion and metastasis, and tumor microenvironment. Nomogram including the five-gene signature was established. Conclusion: A novel five PCD-related gene signature and nomogram could be used for prognostic prediction in TNBC. The present work might offer useful insights in digging sensitive and effective biomarkers for TNBC prognosis prediction and establishing accurate prognostic model in clinical management.
- Open Access
- 26 October 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-15
Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer
Mounting evidence indicate that cuproptosis, a novel form of programmed cell death, contributes to cancer development and progression. However, a comprehensive analysis regarding the expressions, functions, and regulatory network of cuproptosis-related genes is still lacking. In the present work, cuproptosis-related genes, upstream miRNAs and lncRNAs, and clinical data of breast cancer from TCGA database were analyzed by R language including Cox regression analysis, correlation calculation, ROC curve construction, and survival evaluation, and were further verified by public-available databases. Chemosensitivity and immune infiltration were also evaluated by online tools. SLC31A1 was significantly increased in breast cancer samples than those in normal tissues. SLC31A1 was negatively related to a favorable outcome in breast cancer, and the AUC value increased with the prolongation of follow-up time. LINC01614 and miR-204-5p were potential upstream regulators of SLC31A1. Moreover, SLC31A1 was significantly positively correlated with different immune cells infiltration, immune cell biomarkers, and immune checkpoints in breast cancer. SLC31A1 was a potential cuproptosis-related gene in breast cancer, which was significantly upregulated and was able to predict diagnosis, prognosis, chemosensitivity, and immune infiltration. LINC01640/miR-204-5p/SLC31A1 might be a significant and promising axis during cuproptosis in breast cancer.
- 26 October 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-15
Open AccessIdentification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer
Mounting evidence indicate that cuproptosis, a novel form of programmed cell death, contributes to cancer development and progression. However, a comprehensive analysis regarding the expressions, functions, and regulatory network of cuproptosis-related genes is still lacking. In the present work, cuproptosis-related genes, upstream miRNAs and lncRNAs, and clinical data of breast cancer from TCGA database were analyzed by R language including Cox regression analysis, correlation calculation, ROC curve construction, and survival evaluation, and were further verified by public-available databases. Chemosensitivity and immune infiltration were also evaluated by online tools. SLC31A1 was significantly increased in breast cancer samples than those in normal tissues. SLC31A1 was negatively related to a favorable outcome in breast cancer, and the AUC value increased with the prolongation of follow-up time. LINC01614 and miR-204-5p were potential upstream regulators of SLC31A1. Moreover, SLC31A1 was significantly positively correlated with different immune cells infiltration, immune cell biomarkers, and immune checkpoints in breast cancer. SLC31A1 was a potential cuproptosis-related gene in breast cancer, which was significantly upregulated and was able to predict diagnosis, prognosis, chemosensitivity, and immune infiltration. LINC01640/miR-204-5p/SLC31A1 might be a significant and promising axis during cuproptosis in breast cancer.
- Open Access
- 20 September 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (18) , 16779-16795
Identification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer
Background: Breast cancer (BCa) is a major challenge for women’s health worldwide. Ferroptosis is closely related to tumorigenesis and cancer progression. However, the prognostic value of ferroptosis-related genes in BCa remains unclear, and more accurate prognostic models are urgently needed. Methods: Gene expression profiles and clinical information of BCa patients were collected from public databases. LASSO and multivariate Cox regression analysis were utilized to construct the prognostic gene signature. Kaplan–Meier plotter, receiver operating characteristic (ROC) curves, and nomogram were used to validate the prognostic value of the gene signature. Gene set enrichment analysis was performed to explore the molecular functions and signaling pathways. Results: Differentially expressed ferroptosis-related genes between BCa samples and normal tissues were obtained. A novel five-gene signature including BCL2, SLC40A1, TFF1, APOOL, and PRAME was established for prognosis prediction. Patients stratified into high-risk or low-risk group displayed significantly different survival. Kaplan–Meier and ROC curves showed a good performance for survival prediction in different cohorts. Biological function analysis revealed that the five-gene signature was associated with cancer progression, immune infiltration, immune response, and drug resistance. Nomogram including the five-gene signature was established. Conclusion: A novel five ferroptosis-related gene signature and nomogram could be used for prognostic prediction in BCa.
- 20 September 2023
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (18) , 16779-16795
Open AccessIdentification of a novel five ferroptosis-related gene signature as a promising prognostic model for breast cancer
Background: Breast cancer (BCa) is a major challenge for women’s health worldwide. Ferroptosis is closely related to tumorigenesis and cancer progression. However, the prognostic value of ferroptosis-related genes in BCa remains unclear, and more accurate prognostic models are urgently needed. Methods: Gene expression profiles and clinical information of BCa patients were collected from public databases. LASSO and multivariate Cox regression analysis were utilized to construct the prognostic gene signature. Kaplan–Meier plotter, receiver operating characteristic (ROC) curves, and nomogram were used to validate the prognostic value of the gene signature. Gene set enrichment analysis was performed to explore the molecular functions and signaling pathways. Results: Differentially expressed ferroptosis-related genes between BCa samples and normal tissues were obtained. A novel five-gene signature including BCL2, SLC40A1, TFF1, APOOL, and PRAME was established for prognosis prediction. Patients stratified into high-risk or low-risk group displayed significantly different survival. Kaplan–Meier and ROC curves showed a good performance for survival prediction in different cohorts. Biological function analysis revealed that the five-gene signature was associated with cancer progression, immune infiltration, immune response, and drug resistance. Nomogram including the five-gene signature was established. Conclusion: A novel five ferroptosis-related gene signature and nomogram could be used for prognostic prediction in BCa.